Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clorpactin intravesical instillation for bladder pain syndrome/interstitial cystitis
ACTRN12611000717954Phase 3Completed
- Sponsor
- Mercy Hospital for Women
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sodium oxychlorosene in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS) (2 arms), sponsored by Mercy Hospital for Women. Primary endpoint: Subject improvement as reflected in the Global response assessment. Started Mar 2012; status: completed.
02
Drugs
sodium oxychlorosene
03
Conditions
Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)
Beyond the preview
Go deeper on ACTRN12611000717954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000717954.